MXPA02000915A - Composiciones que contienen agentes activos derivados de musculo. - Google Patents
Composiciones que contienen agentes activos derivados de musculo.Info
- Publication number
- MXPA02000915A MXPA02000915A MXPA02000915A MXPA02000915A MXPA02000915A MX PA02000915 A MXPA02000915 A MX PA02000915A MX PA02000915 A MXPA02000915 A MX PA02000915A MX PA02000915 A MXPA02000915 A MX PA02000915A MX PA02000915 A MXPA02000915 A MX PA02000915A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- pharmaceutical
- matter
- active agents
- compositions containing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 210000003205 muscle Anatomy 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000002254 cytotoxic agent Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13109699A IL131096A (en) | 1999-07-26 | 1999-07-26 | Method for preparing a composition derived from muscle tissue |
| PCT/IL2000/000395 WO2001007060A1 (en) | 1999-07-26 | 2000-07-06 | Compositions containing muscle-derived active agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02000915A true MXPA02000915A (es) | 2003-07-14 |
Family
ID=11073063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02000915A MXPA02000915A (es) | 1999-07-26 | 2000-07-06 | Composiciones que contienen agentes activos derivados de musculo. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6537587B1 (es) |
| EP (1) | EP1204418B1 (es) |
| JP (1) | JP2003505425A (es) |
| CN (1) | CN1195529C (es) |
| AT (1) | ATE338559T1 (es) |
| AU (1) | AU758856C (es) |
| CA (1) | CA2378726A1 (es) |
| DE (1) | DE60030567T2 (es) |
| IL (1) | IL131096A (es) |
| MX (1) | MXPA02000915A (es) |
| WO (1) | WO2001007060A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL127947A0 (en) | 1999-01-07 | 1999-11-30 | Can Fite Technologies Ltd | Pharmaceutical use of adenosine agonists |
| US6790839B2 (en) | 1999-01-07 | 2004-09-14 | Can-Fite Biopharma Ltd. | Pharmaceutical administration of adenosine agonists |
| IL131096A (en) | 1999-07-26 | 2004-09-27 | Can Fite Technologies Ltd | Method for preparing a composition derived from muscle tissue |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| JP4712256B2 (ja) * | 2001-09-28 | 2011-06-29 | 東海物産株式会社 | 高品位チキンエキス含有機能性食品とその製造方法 |
| JP4712257B2 (ja) * | 2001-09-28 | 2011-06-29 | 東海物産株式会社 | チキンエキス膜処理物及びその含有物の製造法 |
| US20060153797A1 (en) * | 2004-06-11 | 2006-07-13 | Bortolotto Susan K | Tissue material and matrix |
| CN100335066C (zh) * | 2005-04-07 | 2007-09-05 | 暨南大学 | 一种肌肉匀浆提取物及其制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1345565A (fr) * | 1962-01-19 | 1963-12-13 | Rolland Lab A | Procédé pour l'obtention d'extraits totaux plus généralement orginaires de tissus viants |
| IN161706B (es) * | 1983-10-05 | 1988-01-16 | Solco Basel Ag | |
| US5242692A (en) * | 1990-07-10 | 1993-09-07 | Bar Ilan University | Anti-metastatic factor |
| IL111021A0 (en) * | 1994-09-22 | 1994-11-28 | Mor Research Applic Ltd | Factor derived from muscle cells |
| IL121272A (en) | 1997-07-10 | 2000-06-01 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia |
| IL131096A (en) | 1999-07-26 | 2004-09-27 | Can Fite Technologies Ltd | Method for preparing a composition derived from muscle tissue |
-
1999
- 1999-07-26 IL IL13109699A patent/IL131096A/en not_active IP Right Cessation
-
2000
- 2000-07-06 EP EP00944187A patent/EP1204418B1/en not_active Expired - Lifetime
- 2000-07-06 WO PCT/IL2000/000395 patent/WO2001007060A1/en not_active Ceased
- 2000-07-06 AT AT00944187T patent/ATE338559T1/de not_active IP Right Cessation
- 2000-07-06 MX MXPA02000915A patent/MXPA02000915A/es active IP Right Grant
- 2000-07-06 DE DE60030567T patent/DE60030567T2/de not_active Expired - Fee Related
- 2000-07-06 JP JP2001511943A patent/JP2003505425A/ja active Pending
- 2000-07-06 AU AU58418/00A patent/AU758856C/en not_active Ceased
- 2000-07-06 US US09/700,745 patent/US6537587B1/en not_active Expired - Fee Related
- 2000-07-06 CN CNB008122962A patent/CN1195529C/zh not_active Expired - Fee Related
- 2000-07-06 CA CA002378726A patent/CA2378726A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6537587B1 (en) | 2003-03-25 |
| CA2378726A1 (en) | 2001-02-01 |
| JP2003505425A (ja) | 2003-02-12 |
| WO2001007060A1 (en) | 2001-02-01 |
| AU5841800A (en) | 2001-02-13 |
| DE60030567D1 (de) | 2006-10-19 |
| AU758856B2 (en) | 2003-04-03 |
| EP1204418A1 (en) | 2002-05-15 |
| IL131096A0 (en) | 2001-01-28 |
| CN1195529C (zh) | 2005-04-06 |
| EP1204418B1 (en) | 2006-09-06 |
| AU758856C (en) | 2003-11-20 |
| DE60030567T2 (de) | 2007-05-31 |
| ATE338559T1 (de) | 2006-09-15 |
| IL131096A (en) | 2004-09-27 |
| CN1399553A (zh) | 2003-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU227992B1 (en) | Interferon conjugates, process for prepairing them, pharmaceutical compositions, containing them and use of them | |
| EG20380A (en) | Enhanced skin penetration system for improved topical delivery of drugs | |
| SK137996A3 (en) | Cancer treatment and metastasis prevention | |
| JPS6388128A (ja) | 腫瘍細胞転移抑制剤 | |
| JPH08502074A (ja) | 組織の保護及び再生組成物 | |
| KR20100119541A (ko) | 단백질 및 펩티드 치료제의 경구 투여 방법 및 조성물 | |
| CZ200487A3 (cs) | Léčivo pro zvýšení účinnosti terapie rakoviny | |
| MXPA02000915A (es) | Composiciones que contienen agentes activos derivados de musculo. | |
| PL342614A1 (en) | Anticarcinogenic drugs | |
| CN106237340A (zh) | 透明质酸纳米颗粒在制备治疗淋巴系统肿瘤的药物的用途 | |
| WO1994022484A1 (en) | Directed delivery of radioprotectants using a receptor specific carrier | |
| Miura et al. | Efficacy of slow-releasing anticancer drug delivery systems on transplantable osteosarcomas in rats | |
| WO2000053219A3 (en) | Compositions and methods for treating cancer and hyperproliferative disorders | |
| He et al. | Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats | |
| JPS62501705A (ja) | 腫瘍性疾患の治療に用いるプログルミド含有医薬組成物 | |
| US4738955A (en) | Anti-carcinoma therapeutic agent of glycosaminoglycans and cytostatic agents | |
| KR20060061367A (ko) | 디파이브로타이드를 단독으로 또는 다른 항암제들과조합하여 포함하는 항암제제 | |
| CA2374681A1 (en) | Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection | |
| GB2421911A (en) | Acid containing oxaliplatin formulations | |
| RU2234323C1 (ru) | Препарат, обладающий противоопухолевым, антитоксическим и радиопротекторным действием | |
| JP2522719B2 (ja) | 褥瘡及び皮膚潰瘍治療外用剤 | |
| JP2842888B2 (ja) | リボヌクレアーゼインヒビターを有効成分とする癌細胞転移抑制剤 | |
| EP0670165B1 (en) | Use of seminal ribonuclease as antimetastatic compound | |
| WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents | |
| AU2002364165B2 (en) | Process for affecting neurologic progression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |